Mark J. Schoenebaum

Mark J. Schoenebaum

51 year
Finance
Consumer Services
Health Technology

Profile

Mark J.
Schoenebaum
worked as a Senior Research Analyst at Piper Sandler & Co., Senior Research Analyst at Bear, Stearns & Co., Senior Analyst at CIBC World Markets Corp., Managing Director at Deutsche Bank Securities, Senior Managing Director at International Strategy & Investment Group LLC, Independent Director at TG Therapeutics, Director at Health Sciences Acquisitions Corp., and Analyst at Alexandra Investment Management LLC.
He received his undergraduate degree from Indiana University and his doctorate from The Johns Hopkins University School of Medicine.

Former positions of Mark J. Schoenebaum

CompaniesPositionEnd
IMMUNOVANT, INC. Director/Board Member 2019-08-23
TG THERAPEUTICS, INC. Director/Board Member 2019-08-23
Analyst-Equity 2015-11-30
Analyst-Equity 2010-05-30
Analyst-Equity 2008-05-30
See the detail of Mark J. Schoenebaum's experience

Training of Mark J. Schoenebaum

Indiana University Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark J. Schoenebaum's experience

Connections

100 +

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
TG THERAPEUTICS, INC.

Health Technology

Private companies8

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Mark J. Schoenebaum